In addition to enabling regenerative medicine, stem cell research promises to enhance drug discovery and development efforts by providing new tools to improve efficacy and toxicity testing, drug screening, novel target discovery, and understanding of disease mechanisms and pathways. Cambridge Healthtech Institute’s Second Annual Stem Cells in Drug Discovery and Development will explore how pharma are incorporating stem cells into their drug discovery/development efforts and the value of stem cell models in compound screening, toxicity assessment, disease modeling, and new target discovery.
